Home
Sandu Pharmaceuticals Ltd Board of Directors
Board of Directors at Sandu Pharmaceuticals Ltd
Non-Exec. & Independent Dir.
Non Executive Director
Chairman & Independent Directo
Non-Exec. & Independent Dir.
Non-Exec. & Independent Dir.
Key Highlights
- Shashank B Sandu continues to serve as the Non-Exec & Non-Independent Dir in 2024, maintaining the same position as in the previous year.
- Umesh B Sandu joins the board as Managing Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Pratika Mhambray joins the board as Company Sec. & Compli. Officer, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Vijay Kottapalli joins the board as Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Jayshree Sandu joins the board as Non Executive Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.

Sandu Pharmaceuticals Ltd
NSE: SANDUPHARMA
Share Price
Last Ten Days Market Price
Date | |
---|---|
03 Apr 2025 | 48.67 |
02 Apr 2025 | 50 |
01 Apr 2025 | 50 |
28 Mar 2025 | 48.99 |
27 Mar 2025 | 46.23 |
26 Mar 2025 | 49.19 |
25 Mar 2025 | 50.22 |
24 Mar 2025 | 51.8 |
21 Mar 2025 | 52.69 |
20 Mar 2025 | 51.47 |
Company Fundamentals for Sandu Pharmaceuticals Ltd
Market Cap
47 Cr
EPS
1.5
P/E Ratio (TTM)
32.2
P/B Ratio (TTM)
1.1
Day’s High
50.0
Day’s Low
48.58
DTE
0.0
ROE
3.6
52 Week High
69.5
52 Week Low
45.15
ROCE
5.3
Market Price of Sandu Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Sandu Pharmaceuticals Ltd News Hub
Sandu Pharmaceuticals AGM scheduled
Sandu Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the company will be he
Read more
13 Aug 24
Board of Sandu Pharmaceuticals recommends final dividend
Sandu Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 12
Read more
13 Aug 24
Sandu Pharmaceuticals consolidated net profit rises 54.55% in the June 2024 quarter
Net profit of Sandu Pharmaceuticals rose 54.55% to Rs 0.17 crore in the quarter ended June 2024 as a
Read more
13 Aug 24
Sandu Pharmaceuticals schedules board meeting
Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 August 2024
Read more
06 Aug 24